Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2026-04-07 @ 12:07 PM
Study NCT ID:
NCT00375661
Status:
COMPLETED
Last Update Posted:
2015-09-02
First Post:
2006-09-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC
Sponsor:
Kyoto University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
O2006-415
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None